Diabetes
Biodel Inc. Announces VIAject Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
Published in Diabetes Week, October 1st, 2007
VIAject(TM) Phase II meal study data was disclosed in an oral presentation at EASD entitled, "Pharmacokinetics and pharmacodynamics of insulin VIAject(TM), insulin lispro and regular human insulin when injected subcutaneously immediately before a meal in patients with Type 1 diabetes." The VIAject (TM) Phase II meal study results demonstrated statistically significant and clinically relevant improved glycemic control compared to regular human insulin (Humulin(R) R) and lispro...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
Source: Diabetes Week (2007-10-01)
More Articles from Diabetes Week
- Diabetes Complications
Older Blacks and Latinos Still Lag Whites in Controlling Diabetes - Type 1 Diabetes
Consumption of Omega-3 Fatty Acids Associated With Decreased Risk of Type 1 Diabetes - Type 1 Diabetes
Immune police recognize good and bad guys in the body - Type 2 Diabetes
Both aerobic and resistance exercise improved blood sugar control in people with diabetes - Alzheimer Disease
The HealthCentral Network Wins Multiple Awards for Excellence in Health on the Web - Diabetes
Digital Healthcare Wins FDA Approval for Retasure - More from this issue of Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
